FindTrial
Sign In

Padmagadi agada (tablet) in Urticaria.

Open Label Single Arm Clinical Study on Efficacy of Padmakadi Agada in Sheetapitta with special reference to Urticaria - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103616
Enrollment
30
Registered
2026-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.full filling diagnostic criteria 2.aged 18 to 60 years with symptoms of shettapitaa 3.Chronicity less than 6 week 4.mild to moderate stages of disease 5.subjects willing to participate and ready for voluntary consent

Exclusion criteria

Exclusion criteria: 1.subject with chronic disease 2.pregnent and lactating mother 3.chronicity more than 6 weeks

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of Padmakadi agada in SheetapittaTimepoint: 8th Day and 15th Day—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Yatheesh K R

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

doc.nattu@gmail.com9844849192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026